Uemura, Yukari
Ozaki, Ryoto
Shinozaki, Tomohiro
Ohtsu, Hiroshi
Shimizu, Yousuke
Izumi, Kazuo
Saito, Sho
Matsunaga, Nobuaki
Ohmagari, Norio
Article History
Received: 27 April 2023
Accepted: 23 November 2023
First Online: 4 December 2023
Declarations
:
: This research was conducted in accordance with ethical principles based on the Declaration of Helsinki and in compliance with the ethical guidelines for medical research involving human subjects. This study was approved by the National Center for Global Health and Medicine Ethics Review Committee (NCGM-G-004119-00) and registered in April 2020 in the UMIN Clinical Trials Registry (UMIN-CTR; ID: UMIN000043622). Informed consent from each patient was obtained in the form of opt-out. Information regarding opting out of our study is available on the registry website. The participants of the source study, JA42434 study, provided informed consent.
: Not applicable
: YU received a consultation fee from Chugai Pharmaceutical Ltd, RO is an employee of Chugai Pharmaceutical Ltd. Rest all other author's have no competing interest